Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 227,800 | 221,083 | 213,365 | 238,202 | 248,360 |
| Cost of Goods | 43,069 | 42,319 | 42,529 | 43,326 | 48,519 |
| Gross Profit | 184,731 | 178,764 | 170,836 | 194,876 | 199,841 |
| Operating Expenses | 160,127 | 154,864 | 153,758 | 170,802 | 173,515 |
| Operating Income | 24,673 | 24,219 | 17,607 | 24,400 | 26,845 |
| Interest Expense | 52 | 145 | 43 | 43 | 31 |
| Other Income | 2,490 | 2,537 | 2,967 | 2,453 | 1,687 |
| Pre-tax Income | 27,111 | 26,611 | 20,531 | 26,810 | 28,501 |
| Income Tax | 10,574 | 9,845 | 9,184 | 9,518 | 10,118 |
| Net Income Continuous | 16,537 | 16,766 | 11,347 | 17,292 | 18,383 |
| Net Income | $16,537 | $16,766 | $11,347 | $17,292 | $18,383 |
| EPS Basic Total Ops | 0.86 | 0.88 | 0.59 | 0.89 | 0.95 |
| EPS Basic Continuous Ops | 0.86 | 0.88 | 0.59 | 0.90 | 0.95 |
| EPS Diluted Total Ops | 0.86 | 0.87 | 0.59 | 0.89 | 0.95 |
| EPS Diluted Continuous Ops | 0.86 | 0.87 | 0.59 | 0.89 | 0.95 |
| EPS Diluted Before Non-Recurring Items | 0.86 | 0.87 | 0.59 | 0.89 | 0.95 |
| EBITDA(a) | $29,757 | $29,090 | $22,766 | $29,541 | $32,069 |